Northwestern Mutual Wealth Management
ADIL

Northwestern Mutual Wealth Management’s Adial Pharmaceuticals ADIL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$7 – 4086
2026
Q1 		$7 Buy
+4
New +$14 ﹤0.01% 4090

Other funds holding ADIL

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Manchester Capital Management Manchester, Vermont $768M AUM 29.32% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northwestern Mutual Wealth Management's ADIL Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Adial Pharmaceuticals (ADIL) in Q2 2026, closing a stake of 4 shares — an estimated $7 sold.

Northwestern Mutual Wealth Management first reported a position in ADIL in Q1 2026 and held it in 1 quarter. The position peaked at $7 in Q1 2026. 17 funds tracked by Wall St. Rank hold ADIL as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Adial Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 4 Adial Pharmaceuticals shares in Q2 2026, an estimated $7.
  • Northwestern Mutual Wealth Management first reported a position in Adial Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Adial Pharmaceuticals position peaked at $7 in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.